Welcome to PLANET-2.com

Groundbreaking study on prophylactic platelet transfusions in newborns

Welcome to PLANET-2.com, the official website of the world's only randomized, controlled trial evaluating the threshold level of effectiveness of prophylactic platelet transfusions in newborns. Our study, known as PLANET-2 (Platelets and Neonatal Transfusion Study), is a milestone in the field of neonatology and transfusionology to improve the health and survival of the youngest patients.

About the PLANET-2 study

PLANET-2 is a study conducted in response to pressing questions about the optimal use of platelet transfusions in newborns, especially those born prematurely or with serious medical conditions. Our primary goal is to determine what threshold level of platelets is most effective in preventing bleeding while minimizing the risk of transfusion-related complications.

Our Mission

PLANET-2's mission is to provide the solid, scientific evidence necessary to develop guidelines and standards of care that can save lives and improve the health of newborns around the world. Through our research, we aim to give neonatologists the tools they need to make informed and best-informed decisions about the care of their youngest patients.

Study Methodology

The PLANET-2 study uses a randomized and controlled methodology, meaning that newborns will be randomly assigned to intervention and control groups. This type of approach eliminates bias and produces the most reliable results.

• Recruitment of participants: Eligible newborns are recruited from hospitals and neonatology units around the world.

• Group allocation: Participants are randomly assigned to one of two groups: those receiving platelet transfusion at higher or lower threshold platelet levels.

• Monitoring and data collection: Each child is carefully monitored, and data on their health and clinical course are systematically collected and analyzed.

Key Conclusions and Expected Results

The PLANET-2 study aims to answer several key questions:
    1. What are the optimal threshold levels of platelets for newborns?
    2. What are the short- and long-term effects of different transfusion strategies?
    3. What are the potential complications associated with different threshold levels?
We expect the results of our study to yield groundbreaking findings that will influence standards of neonatal care and transfusion practices around the world.

Why is PLANET-2 So Important?

Every day, thousands of newborns around the world need platelet transfusions. Without solid evidence of optimal threshold levels, physicians must rely on their own experience and intuition, which can lead to inconsistent practices and varied outcomes. PLANET-2 brings irreplaceable knowledge to the field to standardize and improve care for the most vulnerable patients.

Commitment to Science and Collaboration

PLANET-2 is not just a study, but also a community of engaged scientists, doctors, nurses and patient families. We are proud of our global collaborations and partnerships with leading medical institutions. Together, we are working to bring PLANET-2 results into clinical practice as soon as possible.

Join Us

We invite you to follow our progress, share our knowledge and support our mission. On PLANET-2.com, you'll find the latest updates, scientific publications and opportunities to participate in our educational initiatives.

Together, we can change the future of neonatal care and save many little lives. Thank you for your interest and support.

PLANET-2.com - Your source for the latest information on groundbreaking research on prophylactic platelet transfusions in newborns.